Laronib 100 Mg (Larotrectinib) – 30 Capsules
$ 560.00
Laronib 100 Mg (Larotrectinib) a breakthrough in cancer treatment, is a powerful embodiment of precision medicine. Featuring Larotrectinib, this medication specifically targets cancers with TRK fusions, offering a novel and highly effective treatment for patients with this rare genetic alteration. Laronib targets tumors that exhibit TRK (tropomyosin receptor kinase) gene fusions. These fusions can occur in various types of cancer and drive the growth and spread of cancer cells. Laronib 100 mg’s focus on these specific genetic changes marks a significant departure from traditional, more generalized cancer treatments.
Laronib is used to treat:
- Adult and Pediatric Cancers with TRK Fusions: Laronib 100 mg is effective across a range of tumor types in both adults and children, provided the tumors have TRK fusions.
Product Feature:
Manufacturer | : Everest Pharmaceuticals Ltd. |
Indication | : Tumors TRK (tropomyosin receptor kinase) gene fusions. |
Generic | : Larotrectinib |
Formulation | : Capsule |
Pack Size | : 30 Capsules |
Strengths | : 100 Mg |
Storage | : Below 30°C |
You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Laronib 100 Mg (Larotrectinib) medicine.
Reviews
There are no reviews yet.